{"pmid":32416767,"title":"COVID-19 response in the Middle East and north Africa: challenges and paths forward.","text":["COVID-19 response in the Middle East and north Africa: challenges and paths forward.","Lancet Glob Health","Karamouzian, Mohammad","Madani, Navid","32416767"],"journal":"Lancet Glob Health","authors":["Karamouzian, Mohammad","Madani, Navid"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32416767","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/S2214-109X(20)30233-3","locations":["north Africa"],"topics":["Prevention"],"weight":1,"_version_":1667058206834163712,"score":9.490897,"similar":[{"pmid":32425474,"pmcid":"PMC7233242","title":"Geriatric mental health and COVID-19: An eye-opener to the situation of the Arab countries in the Middle East and North Africa Region.","text":["Geriatric mental health and COVID-19: An eye-opener to the situation of the Arab countries in the Middle East and North Africa Region.","While the detrimental ramifications of the COVID-19 outbreak on the mental wellbeing of the general public continue to unravel, older adults seem to be at high risk. As the geriatric population continues to grow in the Middle East and North Africa (MENA) region, it is essential to explore the influence of this outbreak on geriatric mental health, a topic often neglected. In this review, we depict the status of geriatric psychiatry in the Arab countries of the MENA region, exploring the variations from one nation to another. While some have a null exposure to the field, resources and expertise in other countries range from very limited to extensive. Furthermore, we highlight the measures implemented in the Arab region to address mental health during the COVID-19 outbreak; these tend to be insufficient when targeting the geriatric population. Finally, we provide short- and long-term recommendations to stakeholders that aim at enhancing the mental healthcare of older adults in the Arab countries of the MENA region, particularly during this pandemic.","Am J Geriatr Psychiatry","Hayek, Samer El","Cheaito, Mohamad Ali","Nofal, Marwa","Abdelrahman, Doaa","Adra, Ali","Shamli, Siham Al","AlHarthi, Mansour","AlNuaimi, Nawaf","Aroui, Chaimaa","Bensid, Lynda","Emberish, Alkhansa Mahdi","Larnaout, Amine","Radwan, Ahmed","Slaih, Mohammad","Sinawi, Hamed Al","32425474"],"abstract":["While the detrimental ramifications of the COVID-19 outbreak on the mental wellbeing of the general public continue to unravel, older adults seem to be at high risk. As the geriatric population continues to grow in the Middle East and North Africa (MENA) region, it is essential to explore the influence of this outbreak on geriatric mental health, a topic often neglected. In this review, we depict the status of geriatric psychiatry in the Arab countries of the MENA region, exploring the variations from one nation to another. While some have a null exposure to the field, resources and expertise in other countries range from very limited to extensive. Furthermore, we highlight the measures implemented in the Arab region to address mental health during the COVID-19 outbreak; these tend to be insufficient when targeting the geriatric population. Finally, we provide short- and long-term recommendations to stakeholders that aim at enhancing the mental healthcare of older adults in the Arab countries of the MENA region, particularly during this pandemic."],"journal":"Am J Geriatr Psychiatry","authors":["Hayek, Samer El","Cheaito, Mohamad Ali","Nofal, Marwa","Abdelrahman, Doaa","Adra, Ali","Shamli, Siham Al","AlHarthi, Mansour","AlNuaimi, Nawaf","Aroui, Chaimaa","Bensid, Lynda","Emberish, Alkhansa Mahdi","Larnaout, Amine","Radwan, Ahmed","Slaih, Mohammad","Sinawi, Hamed Al"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425474","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jagp.2020.05.009","keywords":["arab","covid-19","mena region","geriatric psychiatry"],"locations":["North Africa","Arab","Arab","Arab","Arab","North Africa"],"weight":0,"_version_":1667252837882527744,"score":71.961205},{"pmid":32302075,"title":"Africa in the Path of Covid-19.","text":["Africa in the Path of Covid-19.","N Engl J Med","El-Sadr, Wafaa M","Justman, Jessica","32302075"],"journal":"N Engl J Med","authors":["El-Sadr, Wafaa M","Justman, Jessica"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302075","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1056/NEJMp2008193","topics":["Prevention"],"weight":1,"_version_":1666138494779523074,"score":69.20241},{"pmid":32385914,"title":"The path forward: academic neurology responds to COVID-19.","text":["The path forward: academic neurology responds to COVID-19.","Ann Neurol","McArthur, Justin C","32385914"],"journal":"Ann Neurol","authors":["McArthur, Justin C"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32385914","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/ana.25773","topics":["Prevention"],"weight":1,"_version_":1666340102049103873,"score":66.82128},{"pmid":32145185,"pmcid":"PMC7155742","title":"Middle East respiratory syndrome.","text":["Middle East respiratory syndrome.","The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34.3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.","Lancet","Memish, Ziad A","Perlman, Stanley","Van Kerkhove, Maria D","Zumla, Alimuddin","32145185"],"abstract":["The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34.3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention."],"journal":"Lancet","authors":["Memish, Ziad A","Perlman, Stanley","Van Kerkhove, Maria D","Zumla, Alimuddin"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32145185","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1016/S0140-6736(19)33221-0","locations":["Saudi Arabia","Jordan","Saudi Arabia","Riyadh","Jeddah","South Korea"],"countries":["Jordan","Saudi Arabia","Korea, Republic of"],"countries_codes":["JOR|Jordan","SAU|Saudi Arabia","KOR|Korea, Republic of"],"topics":["Transmission","Treatment","Diagnosis","Prevention","Mechanism"],"weight":1,"_version_":1666138490683785218,"score":64.231255},{"pmid":32430309,"title":"Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.","text":["Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.","Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).","Sci Immunol","Bryant, Juliet E","Azman, Andrew S","Ferrari, Matthew J","Arnold, Benjamin F","Boni, Maciej F","Boum, Yap","Hayford, Kyla","Luquero, Francisco J","Mina, Michael J","Rodriguez-Barraquer, Isabel","Wu, Joseph T","Wade, Djibril","Vernet, Guy","Leung, Daniel T","32430309"],"abstract":["Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level)."],"journal":"Sci Immunol","authors":["Bryant, Juliet E","Azman, Andrew S","Ferrari, Matthew J","Arnold, Benjamin F","Boni, Maciej F","Boum, Yap","Hayford, Kyla","Luquero, Francisco J","Mina, Michael J","Rodriguez-Barraquer, Isabel","Wu, Joseph T","Wade, Djibril","Vernet, Guy","Leung, Daniel T"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430309","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1126/sciimmunol.abc6347","weight":0,"_version_":1667342288126214144,"score":60.61105}]}